BioCentury
ARTICLE | Clinical News

AC430: Phase I started

January 3, 2011 8:00 AM UTC

Ambit began a placebo-controlled Phase I trial to evaluate single- and multiple-ascending doses of oral AC430 in healthy volunteers. ...